Multivalent adjuvant immunization to prevent hospital acquired infections
Ended Project Grant Awarded Last action
- Award ID
- R41AI145759
- Recipient
-
Exbaq LLC UEI CRJPYMUA3NL4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,181,997
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $887,998.00 Federal
- $293,999.00 Non-federal
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $293,999 | $0 | |
| Amendment | $293,999 | $293,999 | |
| Original award | $300,000 | $0 |
Quick answers
Who received award R41AI145759?
R41AI145759 was awarded to Exbaq LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 10, 2020.
How much is award R41AI145759 worth?
$1,181,997 has been obligated on R41AI145759: $887,998 in federal funding and $293,999 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award